Jacobs Engineering has been selected by Aerie Pharmaceuticals to provide engineering, procurement and construction management services (EPCM) for Aerie’s first pharmaceutical manufacturing facility, located in the Industrial Development Authority (IDA)’s advanced technology building in Athlone, Ireland.
Under the terms of the contract, Jacobs will outfit Aerie’s manufacturing facility for commercial processing of sterile ophthalmic solutions. The ophthalmic solutions will be compounded, sterile filtered and filled aseptically. Aerie’s lead product candidates are new chemical entities focused on treating patients with glaucoma or ocular hypertension.
“Leveraging our extensive experience in EPCM for fill-finish facilities, we’ll work alongside Aerie to support their important goal of developing first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye,” said Jacobs Life Sciences, Consumer Goods and Manufacturing Senior Vice President and General Manager Ken Gilmartin.
Jacobs has designed more than 30 fill-finish facilities across the world over the past 10 years.